Filing Details
- Accession Number:
- 0000899243-16-022426
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-06-10 16:17:16
- Reporting Period:
- 2016-06-09
- Filing Date:
- 2016-06-10
- Accepted Time:
- 2016-06-10 16:17:16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1596946 | Quotient Ltd | QTNT | In Vitro & In Vivo Diagnostic Substances (2835) | 264719797 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1604628 | Jeremy Stackawitz | Elizabeth House, 9 Castle Street St Helier Y9 JE2 3RT | President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Disposition | 2016-06-09 | 15,000 | $10.00 | 127,741 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Ordinary Shares | Employee Stock Option (right to buy) | $11.92 | 2026-05-31 | 20,000 | 20,000 | Direct | |
Ordinary Shares | Multi-year Performance Based Restricted Stock Units | $0.00 | 2018-12-31 | 20,000 | 20,000 | Direct | |
Ordinary Shares | Multi-year Performance Based Restricted Stock Units | $0.00 | 2018-12-31 | 22,500 | 22,500 | Direct | |
Ordinary Shares | Employee Stock Option (right to buy) | $15.17 | 2025-05-19 | 22,500 | 22,500 | Direct | |
Ordinary Shares | Employee Stock Option (right to buy) | $8.00 | 2024-04-29 | 60,000 | 60,000 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2026-05-31 | 20,000 | 20,000 | Direct |
2018-12-31 | 20,000 | 20,000 | Direct |
2018-12-31 | 22,500 | 22,500 | Direct |
2025-05-19 | 22,500 | 22,500 | Direct |
2024-04-29 | 60,000 | 60,000 | Direct |
Footnotes
- The options will vest and become exercisable in three equal annual installments beginning on June 1, 2017.
- Each Multi-year Performance Based Restricted Stock Unit ("MRSU") represents a contingent right to receive one share of Quotient's ordinary shares. The MRSUs vest upon Quotient's ordinary shares achieving a volume weighted average market price of $40.00 per share for 20 consecutive trading days during the period April 1, 2018 to December 31, 2018.
- Each MRSU represents a contingent right to receive one share of Quotient's ordinary shares. The MRSUs vest upon Quotient's ordinary shares achieving a volume weighted average market price of $60.00 per share for 20 consecutive trading days during the period April 1, 2018 to December 31, 2018.
- 7,500 options vested on 5/20/2016 and remain exercisable, 7,500 will vest on 5/20/2017, 7,500 will vest on 5/20/2018.
- 40,000 options have vested and remain exercisable, 20,000 options will vest on 4/29/2017.